Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.14T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥2.34T2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.10T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income¥68.7bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥80.9bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax¥83.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥139.7bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥108.5bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥52.8bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥58.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥57.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥60.5bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income¥74.2bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥3.30Tat 2025-06-30Cons.Assets IFRS
Total assets¥3.35Tat 2024-12-31Cons.Assets IFRS
Total assets¥3.13Tat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.89Tat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥1.82Tat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥1.41Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥1.53Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥1.59Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥1.12Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.18Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.29Tat 2024-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥132.4bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥118.6bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥138.4bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥67.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥242.8bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥108.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥61.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥329.4bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥116.0bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥35.8bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥58.1bn2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥21.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥65.232025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.872024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥70.652024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥65.222025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥71.862024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥70.652024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio34.0%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio35.2%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio41.2%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥47.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥14.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥32.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥591m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥30.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥493.8bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥492.6bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥53.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2025-01-01 → 2025-06-30¥129.7bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2025-01-01 → 2025-06-30¥127.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥2.5bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2025-01-01 → 2025-06-30¥8.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥273.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥271.8bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥29.5bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥230.7bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥230.5bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥156m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥33.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥45.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥10.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥34.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥331m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥26.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥513.7bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥512.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥50.3bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-06-30¥71.1bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-06-30¥69.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-06-30−¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥271.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥270.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥30.1bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥233.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥232.8bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥132m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥41.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 858
ItemContextValueUnit
Other non current assets nca IFRSCurrentQuarterInstant48646000000JPY
Deferred tax assets IFRSPrior1YearInstant109761000000JPY
Deferred tax assets IFRSCurrentQuarterInstant98675000000JPY
Non current assets IFRSPrior1YearInstant2312966000000JPY
Non current assets IFRSCurrentQuarterInstant2289392000000JPY
Inventories ca IFRSPrior1YearInstant358985000000JPY
Inventories ca IFRSCurrentQuarterInstant355505000000JPY
Trade and other receivables ca IFRSPrior1YearInstant502880000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant432598000000JPY
Other financial assets ca IFRSPrior1YearInstant8570000000JPY
Other financial assets ca IFRSCurrentQuarterInstant10922000000JPY
Other current assets ca IFRSPrior1YearInstant52142000000JPY
Other current assets ca IFRSCurrentQuarterInstant48322000000JPY
Cash and cash equivalents IFRSPrior1YearInstant118617000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant132408000000JPY
Current assets other than assets held for sale ca IFRSPrior1YearInstant1041193000000JPY
Current assets other than assets held for sale ca IFRSCurrentQuarterInstant979754000000JPY
Assets held for sale IFRSPrior1YearInstant-JPY
Assets held for sale IFRSCurrentQuarterInstant32154000000JPY
Current assets IFRSPrior1YearInstant1041193000000JPY
Current assets IFRSCurrentQuarterInstant1011908000000JPY
Assets IFRSPrior1YearInstant3354159000000JPY
Assets IFRSCurrentQuarterInstant3301300000000JPY
Share capital IFRSPrior1YearInstant102046000000JPY
Share capital IFRSCurrentQuarterInstant102046000000JPY
Capital surplus IFRSPrior1YearInstant9497000000JPY
Capital surplus IFRSCurrentQuarterInstant-JPY
Retained earnings IFRSPrior1YearInstant1130931000000JPY
Retained earnings IFRSCurrentQuarterInstant1133761000000JPY
Treasury shares IFRSPrior1YearInstant-251376000000JPY
Treasury shares IFRSCurrentQuarterInstant-250993000000JPY
Other components of equity IFRSPrior1YearInstant190427000000JPY
Other components of equity IFRSCurrentQuarterInstant136906000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant1181525000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant1121720000000JPY
Non controlling interests IFRSPrior1YearInstant352189000000JPY
Non controlling interests IFRSCurrentQuarterInstant285535000000JPY
Equity IFRSPrior1YearInstant1533714000000JPY
Equity IFRSCurrentQuarterInstant1407255000000JPY
Bonds and borrowings ncl IFRSPrior1YearInstant779583000000JPY
Bonds and borrowings ncl IFRSCurrentQuarterInstant814374000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant87398000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant78922000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant54986000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant54069000000JPY
Provisions ncl IFRSPrior1YearInstant7100000000JPY
Provisions ncl IFRSCurrentQuarterInstant9126000000JPY
Liabilities from application of equity method ncl IFRSPrior1YearInstant10458000000JPY
Liabilities from application of equity method ncl IFRSCurrentQuarterInstant8970000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant13622000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass